Kamau Therapeutics

We are a clinical-stage genome engineering company developing therapies through targeted gene integration to address serious and life-threatening diseases. Our platform focuses on precise gene correction and tunable synthetic capabilities in stem and immune cells, enabling us to edit genes or insert functional genetic constructs into specific genomic locations. This approach, grounded in a mechanistic understanding of disease, aims to deliver curative and definitive treatments.